Condition
Bacteremia Caused by Gram-Negative Bacteria clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Bacteremia Caused by Gram-Negative Bacteria clinical trials that are recruiting, at sites in 2 countries (most in Russia (1), Taiwan (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Intravenous polymyxin B and colistin for carbapenem-resistant gram-negative infections
This study looks to see how well intravenous polymyxin B and colistin work and how safe they are in adults with carbapenem-resistant gram-negative bloodstream or lung infections.
-
Evaluating Fluorothiazinone for Preventing Bacterial Infections in Ventilated Patients
This study is testing if a new drug called Fluorothiazinone can help prevent bacterial infections in patients on ventilators in the ICU.
Quick answers
How many Bacteremia Caused by Gram-Negative Bacteria clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Russia (1 trial), Taiwan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.